Abstract: Hepatocellular carcinoma (hereinafter referred to as liver cancer) is one of the most common malignant tumors in China. Surgical resection is the preferred treatment for liver cancer, but the postoperative recurrence and metastasis rates are quite high. Current evidence shows that microvascular invasion (MVI) is an independent risk factor for postoperative recurrence and metas-tasis of liver cancer, but there are still many controversies about the diagnosis, classification, predic-tion and treatment of MVI over the world. The Chinese Association of Liver Cancer of Chinese Medical Doctor Association organizes domestic experts in related fields to form the Chinese Expert Consensus on the Diagnosis and Treatment of Hepatocellular Carcinoma with Microvascular Invasion (2024 Edition) after many discussions and revisions, in order to better guide the diagnosis and treatment of Liver Cancer with MVI and for reference by domestic peers.